NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has sold roughly $2.5 million in mass spectrometry, gas and liquid chromatography, and capillary electrophesis instruments and software to Metabolomics Australia, which will use the tools to provide services to researchers in Australia.
Metabolomics Australia is a National Collaborative Research Infrastructure Strategy Centre that is managed by Bioplatforms Australia, and it is focused on providing services to researchers in medical, agricultural, and environmental applications of metabolomics.
The center includes collaborations with the University of Melbourne, the University of Western Australia, Murdoch University, the Australian Wine Research Institute, and the University of Queensland.